1-3 of 3
Alison J. Moskowitz
Close
Sort by
Journal Articles

Do all patients with primary refractory/first relapse of HL need autologous stem cell transplant?

Alison J. Moskowitz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2022) 2022 (1): 699–705.
https://doi.org/10.1182/hematology.2022000365
Published: 2022
Journal Articles

How to choose first salvage therapy in Hodgkin lymphoma: traditional chemotherapy vs novel agents

Julia Driessen, Sanne H. Tonino, Alison J. Moskowitz, Marie José Kersten
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2021) 2021 (1): 240–246.
https://doi.org/10.1182/hematology.2021000311
Published: 2021
Journal Articles

Optimizing the role of brentuximab vedotin in classical Hodgkin lymphoma therapy

Alison J. Moskowitz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 207–212.
https://doi.org/10.1182/asheducation-2018.1.207
Published: 2018